Physician profile
Dawn E Jaroszewski
NPI 1063479061
$793,577.23
in general payments reported to CMS, 2019-2025
8 companies · $130K in 2025
The $130K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,110 · 2020: $8,955 · 2021: $4,318 · 2022: $3,174 · 2023: $301K · 2024: $344K · 2025: $130K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $759K · Consulting Fee: $13K · Food and Beverage: $2,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $759,126.51 |
| Consulting Fee | $12,665.00 |
| Food and Beverage | $2,228.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $784,435.56 | 2019-2025 | Medline, Nexgen, Walterlorenz Surgical Assist Arm |
| Atricure, INC. | $8,209.30 | 2019-2024 | |
| Kls-Martin L.P. | $238.98 | 2025 | |
| Davol INC. | $155.35 | 2024 | Progel Applicator Spray Tips |
| Edwards Lifesciences Corporation | $143.20 | 2024 | Mitris Resilia Mitral Valve |
| Baxter Healthcare | $133.59 | 2025 | Tisseel, Floseal, Coseal |
| Boston Scientific Corporation | $131.10 | 2024 | |
| Galvanize Therapeutics, INC | $130.15 | 2025 | Aliya System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Jaroszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.